LB Pharmaceuticals Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 |
|---|---|
Revenue | $0 |
Gross Profit | -81 |
EBITDA | -3,475 |
EBIT | -3,556 |
Net Income | -3,556 |
Net Change In Cash | 0 |
Free Cash Flow | -3,373 |
Cash | 269,744 |
Basic Shares | 25,299 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -321 | |||
EBITDA | -30,083 | -63,010 | -1,445 | -12,194 |
EBIT | -30,404 | -63,101 | -1,449 | -12,196 |
Net Income | -25,205 | -63,102 | -6,275 | -14,348 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -35,260 | -53,821 | -12,119 | -2,728 |
Cash | 250,173 | 22,978 | 14,979 | 21,404 |
Basic Shares | 25,299 | 3,539 | 3,540 | 3,540 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.45 |
2025-09-30 | -$0.61 |
2025-06-30 | -$1.44 |
